 |
CANCER & TREATMENTS SUPPORT & SURVIVORSHIP PREVENTION & RISK ASSESSMENT CLINICAL TRIALS & RESEARCH | |
| ||
|
|
Home > Prevention & Risk Assessment > Genetics > Prostate Cancer Genetics Project PublicationsThe articles listed below are a partial listing of research papers co-authored by PCGP investigators. For a complete bibliography or full-text articles, PCGP participants may contact the Project directly at 800-723-9170. A common variant associated with prostate cancer in European and African populationsAmundadottir LT, Sulem P, Gudmundsson J, Helgason A, Baker A, Agnarsson BA, Sigurdsson A, Benediktsdottir KR, Cazier JB, Sainz J, Jakobsdottir M, Kostic J, Magnusdottir DN, Ghosh S, Agnarsson, K, Birgisdottir B, Le Roux L, Olafsdottir A, Blondal T, Andresdottir M, Gretarsdottir OS, Bergthorsson, JT, Gudbjartsson D, Gylfason A, Thorleifsson G, Manolescu A, , Kristjansson K, Geirsson G, Isaksson H, Douglas J, Johannson JE, Balter K, Wiklund F, Montie JE, Yu X, Suarez BK, Ober C, Cooney KA, Gronberg H, Catalona WJ, Einarsson GV, Barkardottir RB, Gulcher JR, Kong A, Thorsteinsdottir U, Stefansson K. Nat Genet 38(6): 652-658, 2006.
Identifying susceptibility genes for prostate cancer-A family-based association study of polymorphisms in CYP17, CYP19, CYP11A1, and LH-ß.Douglas JA, Zuhlke KA, Beebe-Dimmer J, Levin AM, Gruber SB, Wood DP, Cooney KA. Cancer Epidemiol Biomarkers Prev 14(8): 2035-2039, 2005.
A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the International Consortium for Prostate Cancer GeneticsXu J, Dimitrov L, Chang BL, Adams TS, Turner AR, Meyers DA, Eeles RA, Easton DF, Foulkes WD, Simard J, Giles GG, Hopper JL, Mahle L, Moller P, Bishop T, Evans C, Edwards S, Meitz J, Bullock S, Hope Q, The ACTANE Consortium, Hsieh CL, Halpern J, Balise RN, Oakley-Girvan I, Whittemore AS, Ewing CM, Gielzak M, Isaacs SD, Walsh PC, Wiley KE, Isaacs WB, Thibodeau SN, McDonnell SK, Cunningham JM, Zarfas KE, Hebbring S, Schaid DJ, Friedrichsen DM, Deutsch K, Kolb S, Badzioch M, Jarvik GP, Janer M, Hood L, Ostrander EA, Stanford JL, Lange EM, Beebe-Dimmer JL, Mohai CE, Cooney KA, Ikonen T, Baffoe-Bonnie A, Fredriksson H, Matikainen MP, Tammela TLJ, Bailey-Wilson J, Schleutker J, Maier C, Herkommer K, Hoegel J, Vogel W, Paiss T, Wiklund F, Emanuelsson M, Stenman E, Jonsson BA, Grönberg H, Camp NJ, Farnham J, Cannon Albright LA, Seminara D. Am J Hum Genet 77(2): 219-229, 2005.
Truncating BRCA1 mutations are uncommon in a cohort of hereditary prostate cancer families with evidence of linkage to 17q markersZuhlke KA, Madeoy JJ, Beebe-Dimmer J, White KA, Griffin A, Lange EM, Gruber SB, Ostrander EA, Cooney KA. Clin Cancer Res 10(18): 5975-5980, 2004.
Genome-wide scan for prostate cancer susceptibility genes using families from the University of Michigan Prostate Cancer Genetics Project finds evidence for linkage on chromosome 17 near BRCA1Lange EM, Gillanders EM, Davis CC, Brown WM, Campbell JK, Jones M, Gildea D, Riesdesel E, Albertus J, Freas-Lutz D, Markey C, Giri V, Beebe Dimmer J, Montie JE, Trent JM, Cooney KA. Prostate 57(4): 326-334, 2003.
Prostate cancer early detection practices among men with a family history of diseaseBock CH, Peyser PA, Gruber SB, Bonnell SE, Tedesco KL, Cooney KA. Urology 62(3):470-475, 2003.
RNASEL mutations in hereditary prostate cancerChen H, Griffin AR, Wu YQ, Tomsho LP, Zuhlke KA, Lange EM, Gruber SB, Cooney KA. J Med Genet 40(3):e21, 2003.
R726L androgen receptor mutation is uncommon in prostate cancer families in the United StatesGruber SB, Chen H, Tomsho LP, Lee N, Perrone EE, Cooney KA. Prostate 54(4): 306-309, 2003.
Loss of heterozygosity of the putative prostate cancer susceptibility gene HPC2/ELAC2 is uncommon in sporadic and familial prostate cancerWu YQ, Chen H, Rubin MA, Wojno KJ, Cooney KA. Cancer Res 61(24):8651-8653, 2001.
Analysis of the prostate cancer-susceptibility locus HPC20 in 172 families affected by prostate cancerBock CH, Cunningham JM, McDonnell SK, Schaid DJ, Peterson BJ, Pavlic RJ, Schroeder JJ, Klein J, French AJ, Marks A, Thibodeau SN, Lange EM, Cooney KA. Am J Hum Genet 68(3):795-801, 2001.
Tissue microarray assessment of prostate cancer tumor proliferation in African-American and White menPerrone EE, Theoharis C, Mucci NR, Hayasaka S, Taylor JMG, Cooney KA, Rubin MA. J Natl Cancer Inst 92(11): 937-939, 2000.
The polymorphic exon 1 androgen receptor CAG repeat in men with a potential inherited predisposition to prostate cancerLange EM, Chen H, Brierley K, Livermore H, Wojno KJ, Langefeld CD, Lange K, Cooney KA. Cancer Epidemiol Biomarkers Prev 9(4): 439-442, 2000.
Advances in our understanding of the inherited predisposition to cancerCooney KA. Michigan Oncology Journal 11-12, Spring 2000.
Linkage analysis of 153 prostate cancer families over a 30-cM region containing the putative susceptibility locus HPCXLange EM, Chen H, Brierley K, Perrone EE, Bock CH, Gillanders E, Ray ME, Cooney KA. Clin Cancer Res 5(12): 4013-4020, 1999.
Absence of PTEN germ-line mutations in men with a potential inherited predisposition to prostate cancerCooney KA, Tsou HC, Petty EM, Miesfeldt S, Ping XL, Gruener AC, Peacocke M. Clin Cancer Res 5(6): 1387-1391, 1999.
Prostate cancer susceptibility locus on chromosome 1q: a confirmatory studyCooney KA, McCarthy JD, Lange E, Huang L, Miesfeldt S, Montie JE, Oesterling JE, Sandler HM, Lange K. J Natl Cancer Inst 89(13): 955-959, 1997.
|
|
See Also:
University of Michigan Comprehensive Cancer Center This site is part of the U-M Health System. The information presented is not a tool for self diagnosis or a substitute for professional care. © 2008 U-M Comprehensive Cancer Center |
|
| |||||
